NCT00829582View on ClinicalTrials.gov

Intravenous Dose-Escalation Study With ETI-204 in Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

September 30, 2009

Conditions
Healthy Volunteers
Interventions
DRUG

"ETI-204, Anthim"

single intravenous infusion of 120, 240 or 360 mg of ETI-204

OTHER

placebo

single intravenous infusion

Trial Locations (1)

43210

Osu, 5084 Graves 333 W Tenth Ave, Columbus

Sponsors
All Listed Sponsors
lead

Elusys Therapeutics

OTHER

NCT00829582 - Intravenous Dose-Escalation Study With ETI-204 in Adult Volunteers | Biotech Hunter | Biotech Hunter